Literature DB >> 29166506

Is Ki-67, keratin 16, involucrin, and filaggrin immunostaining sufficient to diagnose inflammatory linear verrucous epidermal nevus? A report of eight cases and a comparison with psoriasis vulgaris.

Jing Peng1, Shu-Bin Sun2, Pei-Pei Yang1, Yi-Ming Fan1.   

Abstract

Inflammatory linear verrucous epidermal nevus and linear psoriasis are sometimes hard to differentiate clinically and pathologically. Although immunohistochemical expression of keratin 10 (K10), K16, Ki-67, and involucrin may be useful for differentiating both entities, these results have been reported in only a few cases. We collected data from 8 patients with inflammatory linear verrucous epidermal nevus, 11 with psoriasis vulgaris, and 8 healthy controls and evaluated immunohistochemical expression of Ki-67, K16, involucrin, and filaggrin among them. Ki-67 and K16 overexpression was similar in inflammatory linear verrucous epidermal nevus and psoriasis vulgaris compared with normal skin. Although staining for involucrin showed discontinuous expression in parakeratotic regions in 4 inflammatory linear verrucous epidermal nevus cases, it was continuous in the other 4 cases and in all psoriasis vulgaris cases. Filaggrin expression was present in hyperkeratotic regions but scarce in parakeratotic areas in both inflammatory linear verrucous epidermal nevus and psoriasis vulgaris. The immunostaining pattern of Ki-67, K16, involucrin, and filaggrin may be insufficient to discriminate inflammatory linear verrucous epidermal nevus from psoriasis vulgaris.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29166506      PMCID: PMC5674702          DOI: 10.1590/abd1806-4841.20176263

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


INTRODUCTION

Inflammatory linear verrucous epidermal nevus (ILVEN) is a rare variant of verrucous epidermal nevus that usually occurs in infancy and rarely in adulthood. It is characterized clinically by pruritic, erythematous, verrucous plaques following Blaschko lines, and pathologically by alternating parakeratosis with hypogranulosis and orthokeratosis with hypergranulosis.[1] ILVEN may sometimes be hard to distinguish from linear psoriasis because of their clinicopathological overlap and concomitance.[2-5] Although immunohistochemical expression of keratin 10 (K10), K16, Ki-67 and involucrin may be useful for differentiating ILVEN from linear psoriasis, these results have been reported in only a few ILVEN cases.[2,6-9] We tried to evaluate the expression of Ki-67, K16, involucrin, and filaggrin for the differential diagnosis between ILVEN and psoriasis vulgaris (PV).

MATERIALS AND METHODS

This study collected data from 8 untreated ILVEN patients, 11 PV patients, and 8 healthy controls, but no cases of linear psoriasis. These patients were diagnosed based on clinicopathological features[10] and not associated with systemic disorders. ILVEN patients had no personal and family histories of psoriasis. PV lesional area was <10% of the body surface area. We performed immunohistochemistry on paraffin-embedded sections. Primary antibodies included goat anti-K16 (SC-49176, 1:200; Santa Cruz Biotechnology, CA, USA), mouse anti-involucrin (SC-21748, 1:200; Santa Cruz), filaggrin (SC-66192, 1:200; Santa Cruz), and rabbit anti-Ki-67 (RMA-0542, prediluted; Zhongshan Jinqiao Biotechnology Co Ltd, Beijing, China). Epidermal Ki-67+ cells were reckoned in 5 different fields at × 200 magnification and expressed in mm of the basement membrane.[11] The data were analyzed using ANOVA with Dunnett T3 test.

RESULTS

Clinical data of 8 ILVEN cases are listed in table 1. Mean age and disease course were 36.6 ± 25.0 and 20.1 ± 13.3 years, respectively. All patients presented with localized or linear verrucous papules, nodules, or plaques (Figure 1A). All patients but one had intense pruritus. Typical pathological features were epidermal acanthosis, alternating parakeratosis with hypogranulosis, orthokeratosis with hypergranulosis, and perivascular lymphocytic dermal infiltration (Figure 1B).
Table 1

Clinical features and involucrin expression in 8 patients with ILVEN

CaseGenderAge/durationLesional distributionInvolucrin expression
1Male55/30 yearsRight cheek, neck, axilla, and inner thighDiscontinuous
2Male5/0.2 yearsPerianal areaDiscontinuous
3Male14/13.7 yearsLeft lower lipDiscontinuous
4Female8/5 yearsLeft forearm, thigh, and legDiscontinuous
5Male41/20 yearsLeft inner thigh and upper legContinuous
6Male42/25 yearsRight thigh, leg, and dorsal footContinuous
7Female73/40 yearsLeft templeContinuous
8Male55/27 yearsLeft inner and anterior thigh and posterior legContinuous
Figure 1

Clinicopathological presentation of ILVEN in case 8. A. Linearly arranged brown verrucous nodules and plaques along the left inner thigh and posterior leg. B. Epidermal acanthosis, alternating parakeratosis with agranulosis, orthokeratosis with hypergranulosis, and perivascular lymphocytic infiltration (Hematoxylin & eosin, scale bar = 200µm)

Clinical features and involucrin expression in 8 patients with ILVEN Clinicopathological presentation of ILVEN in case 8. A. Linearly arranged brown verrucous nodules and plaques along the left inner thigh and posterior leg. B. Epidermal acanthosis, alternating parakeratosis with agranulosis, orthokeratosis with hypergranulosis, and perivascular lymphocytic infiltration (Hematoxylin & eosin, scale bar = 200µm) Eleven PV cases comprised 8 males and 3 females. The average age and disease course were 34.6 ± 15.8 and 3.4 ± 4.3 years, respectively. Eight controls included 7 males and 1 female, with average age of 39.9 ± 9.8 years. Ki-67 was expressed in the basal and parabasal keratinocyte layers of the epidermis, pilosebaceous units, and in some eccrine duct cells. Epidermal Ki-67+ cells in ILVEN (6.86 ± 2.34) and PV (5.31 ± 2.54) were higher than those of normal skin (1.78 ± 0.83) (p < 0.01), but the difference between ILVEN and PV was not significant (p > 0.05). K16 expression was absent in the epidermis of the normal skin. However, we observed K16 expression from the suprabasal layer to the horny layers of parakeratotic regions, while its expression was absent or present only in the spinous layers of hyperkeratotic regions in ILVEN and PV patients. Filaggrin was expressed in the horny and granular layers in normal skin. However, its expression was evident in the lower horny and granular layers of hyperkeratotic areas but deficient in parakeratotic areas in ILVEN and PV patients. We detected involucrin expression in the granular and upper spinous layers in normal skin, but it extended into the middle spinous layer in ILVEN and PV patients. Involucrin showed discontinuous staining (e.g., increased expression in hyperkeratotic regions but absent in parakeratotic regions) in 4 ILVEN cases, but continuous staining in the other ILVEN cases and in all PV cases (Table 1, Figures 2 and 3).
Figure 2

A. Discontinuous involucrin immunostaining in ILVEN (immunostaining, scale bar = 100 m). B. Continuous involucrin immunostaining in ILVEN (immunostaining, scale bar = 100µm)

Figure 3

Continuous involucrin immunostaining in psoriasis vulgaris (immunostaining, scale bar = 100µm)

A. Discontinuous involucrin immunostaining in ILVEN (immunostaining, scale bar = 100 m). B. Continuous involucrin immunostaining in ILVEN (immunostaining, scale bar = 100µm) Continuous involucrin immunostaining in psoriasis vulgaris (immunostaining, scale bar = 100µm)

DISCUSSION

Expression patterns for Ki-67 and K16 are upregulated in PV cases, and their expression is documented in a few ILVEN cases. Incremental Ki-67+ cells and local K16 staining were seen in 4 ILVEN cases.[6,11,12] Ki-67 expression tended to be lower in 3 ILVEN cases than in 4 psoriatic cases but with a remarkable overlap.[7] In a study, a female patient initially considered to have linear psoriasis was finally diagnosed as ILVEN based on a lower Ki-67 expression.[2] However, our study uncovered an analogous overexpression of Ki-67 and K16 in ILVEN and PV patients. Diffuse and intense K16 staining was observed from the suprabasal layer to the horny layers of parakeratotic regions, while its expression was absent or weak in the spinous layers of hyperkeratotic regions in both ILVEN and PV cases. Hence, our results reveal that epidermal hyperproliferation is comparable in both disorders and Ki-67 is not a potential marker to distinguish them. Since K16-related inflammatory response could be involved in epidermal hyperproliferation,[13] disparate K16 distribution and intensity between parakeratotic and hyperkeratotic areas might suggest distinct alterations of keratinocytic activation and proliferation. Involucrin overexpression and filaggrin down-expression are existent in psoriatic lesions.[14-16] Involucrin expression was evident in orthokeratotic regions, but scanty in parakeratotic regions in 4 ILVEN cases, while suprabasal keratinocytes expressed involucrin in parakeratotic areas of psoriasis.[8,9] Some authors considered that involucrin immunostaining might be valuable to distinguish between ILVEN and psoriasis.[8,9,17] However, we observed that involucrin staining was discontinuous in parakeratotic regions in 4 ILVEN cases, while its staining was continuous in the other ILVEN cases and in all PV cases, suggesting that involucrin immunostaining may be unreliable for differentiating both entities. Furthermore, filaggrin expression was present in hyperkeratotic regions but scarce in parakeratotic areas in ILVEN and PV. These results demonstrate that both ILVEN and PV might have an immature epidermal cornification.[14] In parakeratotic areas, lack of filaggrin expression can result from an absent granular layer because its expression is restricted to horny and granular layers in normal skin; the absence of involucrin staining, however, might be due to insufficient production of cytokines since some cytokines can reinforce involucrin expression in both normal and psoriatic keratinocytes.[14] In summary, our results demonstrate that immunostaining patterns for Ki-67, K16, involucrin, and filaggrin may be insufficient to differentiate between ILVEN and PV.
  16 in total

Review 1.  Inflammatory linear verrucous epidermal nevus: a case report and short review of the literature.

Authors:  Amor Khachemoune; Shahbaz A Janjua; Kjetil Kristoffer Guldbakke
Journal:  Cutis       Date:  2006-10

2.  Histopathogenesis of inflammatory linear verrucose epidermal naevus: histochemistry, immunohistochemistry and ultrastructure.

Authors:  M Ito; N Shimizu; H Fujiwara; T Maruyama; M Tezuka
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

3.  Inflammatory linear verrucous epidermal naevus (ILVEN) versus linear psoriasis. A clinical, histological and immunohistochemical study.

Authors:  E de Jong; H F Rulo; P C van de Kerkhof
Journal:  Acta Derm Venereol       Date:  1991       Impact factor: 4.437

4.  Acitretin narrow-band TL-01 phototherapy but not etanercept treatment improves a localized inflammatory linear verrucous epidermal naevus with concomitant psoriasis.

Authors:  M Ozdemir; I Mevlitoğlu; A Balevi
Journal:  J Eur Acad Dermatol Venereol       Date:  2009-03-11       Impact factor: 6.166

5.  Unusual presentation of inflammatory linear verrucous epidermal naevus mimicking linear psoriasis successfully treated with oral retinoid.

Authors:  G-Y Chu; S C-S Hu; C-C E Lan
Journal:  J Eur Acad Dermatol Venereol       Date:  2014-06-09       Impact factor: 6.166

6.  Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.

Authors:  H J Bovenschen; M M B Seyger; P C M Van de Kerkhof
Journal:  Br J Dermatol       Date:  2005-07       Impact factor: 9.302

7.  Immunohistochemical differentiation between inflammatory linear verrucous epidermal nevus (ILVEN) and psoriasis.

Authors:  W H P M Vissers; L Muys; P E J Van Erp; E M G J de Jong; P C M van de Kerkhof
Journal:  Eur J Dermatol       Date:  2004 Jul-Aug       Impact factor: 3.328

8.  Regulation of involucrin in psoriatic epidermal keratinocytes: the roles of ERK1/2 and GSK-3β.

Authors:  Jia-Qi Chen; Xiao-Yong Man; Wei Li; Jiong Zhou; Lilla Landeck; Sui-Qing Cai; Min Zheng
Journal:  Cell Biochem Biophys       Date:  2013-07       Impact factor: 2.194

Review 9.  Unique keratinization process in psoriasis: late differentiation markers are abolished because of the premature cell death.

Authors:  Hajime Iizuka; Hidetoshi Takahashi; Masaru Honma; Akemi Ishida-Yamamoto
Journal:  J Dermatol       Date:  2004-04       Impact factor: 4.005

10.  Involucrin in the differential diagnosis between linear psoriasis and inflammatory linear verrucous epidermal nevus: a report of one case.

Authors:  Flávia Regina Ferreira; Nilton Gioia Di Chiacchio; Márcia Lanzoni de Alvarenga; Samuel Henrique Mandelbaum
Journal:  An Bras Dermatol       Date:  2013 Jul-Aug       Impact factor: 1.896

View more
  1 in total

1.  Esculetin Ameliorates Psoriasis-Like Skin Disease in Mice by Inducing CD4+Foxp3+ Regulatory T Cells.

Authors:  Yuchao Chen; Qunfang Zhang; Huazhen Liu; Chuanjian Lu; Chun-Ling Liang; Feifei Qiu; Ling Han; Zhenhua Dai
Journal:  Front Immunol       Date:  2018-09-12       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.